In the summer of 2006, a previously healthy 16 year old individual presented to the local Accident and Emergency Department, of a Northern Ireland hospital, with a 1.5cm diameter abscess over the left great toe, surrounded by cellulitis. The lesion had failed to respond to oral flucloxacillin prescribed by the family doctor. Apart from trauma to the toe three weeks previously, the patient had no significant past medical history and no risk factors for the acquisition of meticillin-resistant Staphylococcus aureus (MRSA). The lesion required incision and drainage on two occasions. Culture of pus revealed MRSA and treatment was changed to oral doxycyline. Phenotypically, the organism behaved unusually, in that it was sensitive to ciprofloxacin, unlike the majority of other MRSA isolates seen. Detailed molecular work-up of the isolate demonstrated that it carried the Panton Valentine Leukocidin (PVL) gene locus and belonged to subclass IV of the Staphylococcal Chromosomal Cassette (SCCmec), a typical microbiological characteristic of community-associated MRSA (CA-MRSA).
To date, there has been an extensive awareness of MRSA within healthcare facilities, particularly hospitals. More recently, there has been increased reporting of MRSA occurring in the community amongst healthy individuals who have no hospital association. 1 Most recently, the first nosocomial outbreak of community-associated MRSA, has been described in the West Midlands.
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Eight cases of PantonValentine Leukocidin (PVL) positive community-associated MRSA (CA-MRSA) were identified among individuals in a hospital and their close household contacts, of whom four individuals developed an infection, which was fatal in two cases. Transmission of the CA-MRSA strain appeared to have occurred on two separate wards and went undetected until a fatal case was examined in detail.
These organisms are termed CA-MRSA (communityassociated MRSA) and differ significantly from healthcareassociated MRSA (HA-MRSA). Although all are Staphylococcus aureus, they have distinct epidemiological and microbiological characteristics which are summarised in Tables I and II 
Site of infection
Predominantly wound, bacteraemia, (including infective endocarditis), enterotoxin-mediated food-poisoning.
Bacteraemia & wound infections Also symptomatic infections of respiratory and urinary tracts.
Mainly skin (abscesses and cellulitis, furunculosis, severe skin and soft tissue infections (sSSTIs).
In severe cases, septic shock & bacteraemia. Therefore, given the important clinical and epidemiological differences between these types of MRSA, it is important that local physicians have a comprehension of CA-MRSA and that any presumptive CA-MRSA isolates that begin to emerge in Northern Ireland are confirmed and further characterized, so that we can quickly gain an understanding of the diversity/relatedness of such isolates to help guide local guidelines/practice and interventions to minimize its occurrence.
Risk factors
In conclusion, this initial report of CA-MRSA in Northern Ireland, from a 16 year old patient, is typical of CA-MRSA presentation. Firstly, it occurred in a young otherwise healthy individual, with a history of recent trauma. Secondly, the signs and symptoms, namely cellulitis with a large abscess, requiring drainage, was consistent with CA-MRSA skin/soft tissue infection. Thirdly, the resulting cultured MRSA was unusual, in that it was sensitive to ciprofloxacin on in vitro antibiotic susceptibility testing, suggesting the presence of a CA-MRSA organism. Thus, GPs, dermatologists and A&E physicians should beware of the emergence of CA-MRSA locally and should consider and manage such an organism in patients presenting with such symptoms.
